Published in Clin Immunol Immunopathol on January 01, 1987
The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol (1991) 1.68
The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans. Clin Exp Immunol (1989) 1.24
PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect Immun (2007) 1.17
Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol (1992) 1.03
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest (1989) 0.97
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1995) 0.94
Immune complex processing in C1q-deficient mice. Clin Exp Immunol (2001) 0.90
Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.81
Complement-regulatory protein expression and activation of complement cascade on erythrocytes from patients with rheumatoid arthritis (RA). Clin Exp Immunol (1998) 0.76
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Rituximab treatment of idiopathic membranous nephropathy. Kidney Int (2007) 2.85
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest (1997) 2.48
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Self-propelled Leidenfrost droplets. Phys Rev Lett (2006) 2.36
Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant (2013) 2.35
Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med (Berl) (2005) 2.29
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
Improved immunoturbidimetric assay for cystatin C. Ann Clin Biochem (2001) 2.09
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant (2011) 1.98
Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol (2001) 1.84
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Interaction of virulent and avirulent Listeria monocytogenes with cultured mouse peritoneal macrophages. Infect Immun (1973) 1.79
Glycated haemoglobin: an assessment of high capacity liquid chromatographic and immunoassay methods. Ann Clin Biochem (1992) 1.78
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant (2009) 1.71
Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant (2006) 1.70
Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest (1992) 1.69
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Physiological and pathological aspects of circulating immune complexes. Kidney Int (1989) 1.57
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans. Genes Immun (2008) 1.53
Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest (1990) 1.51
Regulation of phagocytosis and [Ca2+]i flux by distinct regions of an Fc receptor. Science (1991) 1.48
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest (2000) 1.42
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care (2002) 1.39
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
Fc gamma receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fc gamma receptor II. J Immunol (1991) 1.38
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
The glycosyl phosphatidylinositol-linked Fc gamma RIIIPMN mediates transmembrane signaling events distinct from Fc gamma RII. J Exp Med (1990) 1.31
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood (2001) 1.25
Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant (2007) 1.25
Antibodies to DNA. A perspective. Arthritis Rheum (1986) 1.24
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant (2004) 1.23
Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant (2007) 1.19
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum (1981) 1.16
Genetic associations of LYN with systemic lupus erythematosus. Genes Immun (2009) 1.15
Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol (1983) 1.13
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant (2006) 1.12
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
An autonomous surgical robot for drilling a cochleostomy: preliminary porcine trial. Clin Otolaryngol (2008) 1.10
Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immun (2009) 1.10
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun (2012) 1.08
Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant (2008) 1.07
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun (2011) 1.07
Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun (2009) 1.07
Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function. J Immunol (1993) 1.07
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. J Immunol (2001) 1.07
The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun (2011) 1.06
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Antineutrophil cytoplasmic antibodies preferentially engage Fc gammaRIIIb on human neutrophils. J Immunol (1998) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol Rev (2001) 1.03
Receptors for immunoglobulin G. Molecular diversity and implications for disease. Arthritis Rheum (1995) 1.03
Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol (1991) 1.02
DNA/anti-DNA complexes: correlation of size and complement fixation. Arthritis Rheum (1981) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol (1994) 1.01
The effect of sodium hydroxide and hydrochloric acid on human epidermis. An electronmicroscopic study. Acta Derm Venereol (1972) 1.01
In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets. J Immunol (1985) 1.01
Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus. Arthritis Rheum (1979) 1.01
Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int (1992) 1.00
Genomic organization of classical human low-affinity Fcgamma receptor genes. Genes Immun (2002) 1.00
Identification of the Kna/Knb polymorphism and a method for Knops genotyping. Transfusion (2004) 0.99
Stability of DNA/anti-DNA complexes. II. Salt lability and avidity. J Immunol (1980) 0.98
Cross-linking of Fc gamma receptor IIa and Fc gamma receptor IIIb induces different proadhesive phenotypes on human neutrophils. J Immunol (1997) 0.98
Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res (2009) 0.98
Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest (1989) 0.97
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Circulation (1993) 0.97